Becker muscular dystrophy mice showed site-specific decay of type IIa fibers with capillary change in skeletal muscle
eLife · 2025
DOI: 10.7554/elife.100665 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Daigo Miyazaki und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Capillaries, Muscle, Skeletal, Muscle Fibers, Skeletal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science, and Technology of Japan.
Abstract (Originalsprache)
Becker muscular dystrophy (BMD), an X-linked muscular dystrophy, is mostly caused by an in-frame deletion of Duchenne muscular dystrophy (DMD). BMD severity varies from asymptomatic to severe, associated with the genotype of DMD. However, the underlying mechanisms remain unclear. We established BMD mice carrying three representative exon deletions: ex45–48 del., ex45–47 del., and ex45–49 del. (d45–48, d45–47, and d45–49), with high frequencies and different severities in the human BMD hotspot. All three BMD mice showed muscle weakness, muscle degeneration, and fibrosis, but these changes appeared at different times for each exon deletion, consistent with the severities obtained by the natural history study of BMD. BMD mice showed site-specific muscle changes, unlike mdx mice, which showed diffuse muscle changes, and we demonstrated selective type IIa fiber reduction in BMD mice. Furthermore, BMD mice showed sarcolemmal neuronal nitric oxide synthase (nNOS) reduction and morphological capillary changes around type IIa fibers. These results suggest that capillary changes caused by nNOS reduction may be associated with the mechanism of skeletal muscle degeneration and type IIa fiber reduction in BMD mice. BMD mice may be useful in elucidating the pathomechanisms and developing vascular targeted therapies for human BMD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan.
- Intractable Disease Care Center, Shinshu University Hospital, Matsumoto, Japan.
- Department of Brain Disease Research, Shinshu University School of Medicine, Matsumoto, Japan.
- Department of Regenerative Science and Medicine, Shinshu University, Matsumoto, Japan.
- Research Center for Advanced Science and Technology, Shinshu University, Matsumoto, Japan.
- Department of Clinical Research, NHO Matsumoto Medical Center, Matsumoto, Japan.
ORCID-Profile: Daigo Miyazaki, Akinori Nakamura
Förderung
- Ministry of Education, Culture, Sports, Science, and Technology of Japan
Zitieren
APA
Miyazaki, D., Sato, M., Shiba, N., Yoshizawa, T., & Nakamura, A. (2025). Becker muscular dystrophy mice showed site-specific decay of type IIa fibers with capillary change in skeletal muscle. eLife. https://doi.org/10.7554/elife.100665
Vancouver
Miyazaki D, Sato M, Shiba N, Yoshizawa T, Nakamura A. Becker muscular dystrophy mice showed site-specific decay of type IIa fibers with capillary change in skeletal muscle. eLife. 2025. doi:10.7554/elife.100665
BibTeX
@article{Miyazaki2025,
author = {Miyazaki, Daigo and Sato, Mitsuto and Shiba, Naoko and Yoshizawa, Takahiro and Nakamura, Akinori},
title = {Becker muscular dystrophy mice showed site-specific decay of type IIa fibers with capillary change in skeletal muscle},
journal = {eLife},
year = {2025},
doi = {10.7554/elife.100665}
}
EUVIMED